Botanix Pharmaceuticals’ Post

View organization page for Botanix Pharmaceuticals, graphic

3,223 followers

🔸 Final Sofdra™ Labelling Discussions with FDA 🔸   #Botanix submitted the last label materials to the US FDA for Sofdra™ a pending prescription treatment for excessive underarm sweating. Labelling, the final step before anticipated Sofdra approval, involves wording of product information for patients and physicians. View the ASX release 👉 https://lnkd.in/gmMbtu6e   $BOT #ASX #dermatology #pharmaceuticals #pharma #biotech #innovation #hyperhidrosis #launch

  • No alternative text description for this image

Congrats to you and the team Howie! Full steam ahead

Like
Reply
Jeff Kline

Global Asset Strategy Lead

1mo

Great news Howie!

Like
Reply
Robert Hill

school counsellor at NSW Department of Education and Communities

1mo

Congratulations!

Like
Reply
Chris Van Tuyl

Chief Legal Officer at Dermavant Sciences

1mo

Congrats Howie!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics